Former India Biotech Secretary Defends Clinical Trial Drug Requirement
This article was originally published in PharmAsia News
Executive Summary
M.K. Bahn, India's former Biotechnology Department secretary, defended India's requirement for clinical trials of all drugs during his term, despite recent reports of scores of fatalities during those tests.